Induction of cytochrome P4503A by Taxol in primary cultures of human hepatocytes

Archives of Biochemistry and Biophysics

Volumn 355, Issue 2, 1998, Pages 131-136

  Kostrubsky, Vsevolod E ^a,b   Lewis, Lionel D ^b   Strom, Stephen C ^c   Wood, Sheryl G ^a   Schuetz, Erin G ^d   Schuetz, John D ^d   Sinclair, Peter R ^a,b   Wrighton, Steven A ^e   Sinclair, Jacqueline F ^a,b  

^a VA MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e ELI LILLY AND COMPANY   (United States)

Author keywords

CYP3A; CYP3A4 mRNA; Hepatocytes; Human; Taxol

Indexed keywords

CYTOCHROME P450; DEXAMETHASONE; PACLITAXEL; PHENOBARBITAL; RIFAMPICIN;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL CULTURE; PRIORITY JOURNAL;

EID: 0032528441     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1006/abbi.1998.0730     Document Type: Article

References (35)

1. Rowinsky E. K., Onetto N., Canetta R. M., Arbuck S. G. Semin. Oncol. 19:1992;646-662.
2. Wrighton S., Stevens J. Crit. Rev. Toxicol. 22:1992;1-21.
3. Monsarrat B., Alvinerie P., Wright M., Dubois J., Gueritte-Voegelein F., Guenard D., Donehower R. C., Rowinsky E. K. J. Natl. Cancer Inst. Monogr. 15:1993;39-46.
4. Sonnichsen D., Liu Q., Schuetz E., Schuetz J., Pappo A., Relling M. J. J. Pharmacol. Exp. Ther. 275:1995;566-575.
5. Cresteil T., Monsarrat B., Alvinerie P., Treluyer J. M., Vieira I., Wright M. Cancer Res. 54:1994;386-392.
6. Harris J. W., Rahman A., Kim B-R., Guengerich P. F., Collins J. M. Cancer Res. 54:1994;4026-4035.
7. Chang T. K., Weber G. F., Crespi C. L., Waxman D. J. Cancer Res. 53:1993;5629-5637.
8. Marre F., Sanderink G. J., deSousa G., Gaillard C., Martinet M., Rahmani R. Cancer Res. 56:1996;1296-1302.
9. Martini R., Murray M. Arch. Biochem. Biophys. 303:1993;57-66.
10. Kostrubsky V. E., Lewis L. D., Wood S. G., Sinclair P. R., Wrighton S. A., Sinclair J. F. Toxicol. Appl. Pharmacol. 142:1997;79-86.
11. Anderson C. D., Wang J., Kumar G. N., McMillan J. M., Walle T. Drug Metab. Dispos. 23:1995;1286-1290.
12. Gianni L., Kearns C., Giana A., Vigano L., Locatelli A., Bonnadonna G., Egorin M. J. Clin. Oncol. 13:1995;180-190.
13. Vermorken J., Postrmus P., van Zandwijk N., Koolen M. J. Clin. Oncol. 15:1997;317-329.
14. Spencer C. M., Faulds D. Drugs. 48:1994;794-847.
15. Morel F., Beaune P., Ratanasavank D., Flinois J. P., Guengerich F., Guillouzo A. Toxic. in Vitro. 4:1990;458-460.
16. Kocarek T., Schuetz E., Strom S., Fisher R., Guzelian P. Drug Metab. Dispos. 23:1995;415-421.
17. Schuetz E., Schuetz J., Strom S., Thompson M., Fisher R., Molowa D., Guzelian P. Hepatology. 18:1993;1254-1262.
18. Maurice M., Pichard L., Daujat M., Fabre I., Joyeux H., Domergue J., Maurel P. FASEB J. 6:1992;752-758.
19. Ged C., Rouillon J., Pichard L., Combalbert J., Bressot N., Bories P., Michel H., Beaune P., Maurel P. Br. J. Clin. Pharmacol. 28:1989;373-387.
20. Kostrubsky V. E., Strom S. C., Wood S. G., Wrighton S. A., Sinclair P. R., Sinclair J. F. Arch. Biochem. Biophys. 322:1995;516-520.
21. Shuetz E. G., Wrighton S. A., Safe S. H., Guzelian P. S. Biochemistry. 25:1986;1124-1133.
22. Lowry O., Rosebrough N., Farr A., Randall R. J. Biol. Chem. 193:1951;265-275.
23. Hamilton J., Bement W., Sinclair J., Sinclair P., Wetterhahn K. Biochem. J. 255:1988;267-275.
24. Curi-Pedrosa R., Daujat M., Pichard L., Ourlin J., Clair P., Gevor L., Lesca P., Domergue J., Joyeux H., Fourtanier G., Maurel P. J. Pharmacol. Exp. Ther. 269:1994;384-392.
25. Pichard L., Fabre I., Daujat M., Domergue J., Joyeux H., Maurel P. Mol. Pharmacol. 41:1992;1047-1055.
26. Strom S., Pisarov L., Dorko K., Thompson M., Schuetz J., Schuetz E. Methods Enzymol. 272:1996;388-401.
27. Horwitz S. B. Science. 13:1992;134-136.
28. Rowinsky E. K., Wright M., Monsarrat B., Lesser J. J., Donehower R. C. Cancer Surv. 17:1993;283-304.
29. Lesser G. J., Grossman S. A., Eller S., Rowinsky E. K. Cancer Chemother. Pharmacol. 37:1995;173-178.
30. Chang T. K., Yu L., Maurel P., Waxman D. J. Cancer Res. 57:1997;1946-1954.
31. Lewis L. D., Fitzgerald D. L., Harper P. G., Rogers H. J. Br. J. Clin. Pharmacol. 30:1990;725-732.
32. D'Incalci M., Bolis G., Facchinetti T., Mangioni C., Morasca L., Morazzoni P., Salmona M. Eur. J. Cancer. 15:1979;7-10.
33. Sparreboom A., Huizing M. T., Boesen J. J., Nooijen W. J., van Tellingen O., Beijnen J. H. Cancer Chemother. Pharmacol. 36:1995;299-304.
34. Patten C. J., Thomas P. E., Guy R. L., Lee M., Gonzalez F. J., Guengerich P. F., Yang C. S. Chem. Res. Toxicol. 6:1993;511-518.
35. Thummel K. E., Lee C. A., Kunze K. L., Nelson S. D., Slattery J. T. Biochem. Pharmacol. 45:1993;1563-1569.